President Barack Obama's commitment to health reform was unmistakeable in February 2009, when he launched a budget plan that confirmed that an overhaul of US healthcare was to be the centrepiece of his first year in office.
16 years after his ...
Assessing the impact of the reform on pharma is a cost-benefit exercise. The industry will have to stump up billions over the next decade in rebates, discounts and annual fees on sales. The pay-off: a huge expansion of the insured market, meaning ...
Pharma companies stand to benefit from significant growth in their customer base. Other changes in the pipeline include the creation of a regulatory pathway for biosimilar medicines, new rules governing drug samples and gifts, and a new institute ...
To understand the full significance of the health reform package, look to its impact on insured and uninsured consumers, the states, health professionals, hospitals and the Democrats' political futures.
the uninsured
Consumers – particularly those ...
